2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$5.07+$0.06 (+1.10%)
Price as of Aug 03, 2026 11:33 AM EDT- $137.2MMarket Cap
- 19.29%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$5.07+$0.06 (+1.10%)
UNCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.01 | ||
Change | -$0.29 (-5.47%) | ||
Open | $5.26 | ||
High | $5.29 | ||
Low | $4.98 | ||
Previous Close | $5.30 | ||
Volume | 486,270 | ||
30-Day Average Volume | 1,367,442 | ||
1-Week Change | -7.22% | ||
1-Month Change | 6.82% | ||
1-Year Change | 19.29% | ||
3-Year Change | -57.18% | ||
5-Year Change | -81.85% | ||
Fundamentals | |||
Shares Outstanding | 27.4M | ||
Total Assets | $64.4M | ||
Market Cap | $137.2M | ||
Enterprise Value | $99.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$12.8M | ||
Free Cash Flow | -$6.2M | ||
EBIT | -$12.8M | ||
EBITDA | -$12.8M | ||
Net Working Capital | $37.1M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/20/2025 | ||
Earnings & Revenue